Healthcare -
Biotechnology - NASDAQ - US
$ 10.27
-2.38 %
$ 433 M
Market Cap
-3.4
P/E
URGN - CASH & EQUIVALENTS
Cash & Equivalents URGN - UroGen Pharma Ltd.
95 M
LAST VALUE
46.34%
2 YEAR CAGR
-1.28%
5 YEAR CAGR
41.10%
10 YEAR CAGR